US Patent 7332574 MDL-1 polypeptides
Patent 7332574 was granted and assigned to Schering on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+287 characters)
Article
Patent abstract
The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07332574 MDL-1 polypeptides US Patent 7332574 MDL-1 polypeptides
Infobox
Patent Number
0733257400
Patent Number
733257400
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073325740
Date of Patent
February 19, 2008
0Patent Application Number
107754230
Date Filed
February 10, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073325740
Date of Patent
February 19, 2008
0Patent Application Number
107754230
Date Filed
February 10, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07332574 MDL-1 polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07332574
Date of patent
February 19, 2008
Patent application number
10775423
Date Filed
February 10, 2004
Patent primary examiner
Find more entities like US Patent 7332574 MDL-1 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
